Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review

Journal of the American Academy of Dermatology

Volumn 69, Issue 5, 2013, Pages 799-807

  Mason, Anne ^a   Mason, James ^b   Cork, Michael ^c   Hancock, Helen ^b   Dooley, Gordon ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d Metaxis Ltd   (United Kingdom)

Author keywords

drug administration; drug safety; psoriasis; review; topical; treatment outcome

Indexed keywords

22 OXACALCITRIOL; ANTIPSORIASIS AGENT; BECOCALCIDIOL; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CALCIPOTRIOL; CALCITRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; DESONIDE; DIFLORASONE DIACETATE; DITHRANOL; EMOLLIENT AGENT; FLUTICASONE PROPIONATE; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; MOMETASONE FUROATE; PARICALCITOL; PIMECROLIMUS; PLACEBO; TACALCITOL; TAZAROTENE; ULOBETASOL PROPIONATE; VITAMIN D;

ARTICLE; BIOSIS; COCHRANE LIBRARY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; EMBASE; HUMAN; MAINTENANCE THERAPY; MEDLINE; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCALP; SCISEARCH; SKIN IRRITATION; SYSTEMATIC REVIEW; TOPICAL TREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

BD; CI; CONFIDENCE INTERVAL; DRUG ADMINISTRATION; DRUG SAFETY; IAGI; INVESTIGATOR ASSESSMENT OF GLOBAL IMPROVEMENT; OD; ONCE DAILY; PSORIASIS; REVIEW; SD; SMD; STANDARD DEVIATION; STANDARDIZED MEAN DIFFERENCE; TOPICAL; TREATMENT OUTCOME; TWICE DAILY;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; CHRONIC DISEASE; HUMANS; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84885591102     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.06.027     Document Type: Article

References (28)

1. L. Hellgren Psoriasis-the prevalence in sex, age and occupational groups in total populations in Sweden: morphology, inheritance and association with other skin and rheumatic diseases 1967 Almqvist and Wiksell Stockholm
2. G.G. Krueger, P.R. Bergstresser, N.J. Lowe, J.J. Voorhees, and G.D. Weinstein Psoriasis J Am Acad Dermatol 11 1984 937 947
3. R.D. Simons Additional studies on psoriasis in the tropics and in the starvations camps J Invest Dermatol 12 1949 285 294
4. S.Y. Yip The prevalence of psoriasis in the Mongoloid race J Am Acad Dermatol 10 1984 965 968
5. C.E.M. Griffiths, E. Christophers, J.N.W.N. Barker, R.J.G. Chalmers, S. Chimenti, and G.G. Krueger A classification of psoriasis vulgaris according to phenotype Br J Dermatol 156 2007 258 262
6. P.C.M. van de Kerkhof Combinations and comparisons Clin Dermatol 15 1997 831 834
7. M.A. Gupta, A.K. Gupta, and G.N. Watteel Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders Cutis 61 1998 339 342
8. A.Y. Finlay Coping with psoriasis BMJ 310 1995 1673
9. A.Y. Finlay Psoriasis from the patient's point of view Arch Dermatol 137 2001 352 353
10. A.Y. Finlay, and E.C. Coles The effect of severe psoriasis on the quality of life of 369 patients Br J Dermatol 132 1995 236 244
11. A.Y. Finlay, and G.K. Khan Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use Clin Exp Dermatol 19 1994 210 216
12. S.P. McKenna, S.A. Cook, D. Whalley, L.C. Doward, H.L. Richards, and C.E. Griffiths Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials Br J Dermatol 149 2003 323 331
13. J.P. Ortonne Psoriasis: evaluation of quality of life Ann Dermatol Venereol 127 Suppl 2000 2s19-22
14. H.L. Richards, D.G. Fortune, C.J. Main, and C.E. Griffiths Stigmatization and psoriasis Br J Dermatol 149 2003 209 211
15. R.S. Stern Epidemiology of psoriasis Dermatol Clin 13 1995 717 722
16. J. Mason, A.R. Mason, and M.J. Cork Topical preparations for the treatment of psoriasis: a systematic review Br J Dermatol 146 2002 351 364
17. P.C.M. van de Kerkhof, J. Barker, C.E.M. Griffiths, K. Kragballe, J. Mason, and A. Menter Psoriasis: consensus on topical therapies J Eur Acad Dermatol Venereol 22 2008 859 870
18. National Clinical Guideline Center Assessment and management of psoriasis, NICE clinical guideline 153 2012 Royal College of Physicians London
19. American Academy of Dermatology Work Group A. Menter, N.J. Korman, C.A. Elmets, S.R. Feldman, J.M. Gelfand, and K.B. Gordon Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6 J Am Acad Dermatol 65 2011 137 174
20. J.W. Fluhr, C. Cavallotti, and E. Berardesca Emollients, moisturizers, and keratolytic agents in psoriasis Clin Dermatol 26 2008 380 386
21. A.R. Mason, J. Mason, M. Cork, G. Dooley, and H. Hancock Topical treatments for chronic plaque psoriasis Cochrane Database of Systematic Reviews 3 2013 10.1002/14651858 Art.No.:CD005028
22. Review Manager (RevMan) [Computer program]. Version 5.2 2012 Nordic Cochrane Center, Cochrane Collaboration Copenhagen
23. Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from: URL: www.cochrane-handbook.org.
24. G.B.E. Jemec, C. Ganslandt, J.-P. Ortonne, Y. Poulin, A.D. Burden, and P. de Unamuno A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial J Am Acad Dermatol 59 2008 455 463
25. S. Tyring, N. Mendoza, M. Appell, A. Bibby, R. Foster, and T. Hamilton A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial Int J Dermatol 49 2010 1328 1333
26. J.D. Bos, and P.I. Spuls Topical treatments in psoriasis: today and tomorrow Clin Dermatol 26 2008 432 437
27. U.R. Hengge, T. Ruzicka, R.A. Schwartz, and M.J. Cork Adverse effects of topical glucocorticosteroids J Am Acad Dermatol 54 2006 1 15 quiz 16-8
28. W. Carey, S. Glazer, A.B. Gottlieb, M. Lebwohl, C. Leonardi, and A. Menter Relapse, rebound, and psoriasis adverse events: an advisory group report J Am Acad Dermatol 54 Suppl 2006 S171 S181